Price
Target price
€2.09
€2.09
0.000%
-
0.000%
-
11:56 / Tradegate
WKN: 520394 / Name: B.R.A.I.N. Biotechnology / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock B.R.A.I.N. Biotechnology Research and Information Network AG is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for B.R.A.I.N. Biotechnology
sharewise wants to provide you with the best news and tools for B.R.A.I.N. Biotechnology, so we directly link to the best financial data sources.
Financials
News
EQS-News: BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25
EQS-News: BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25
EQS-News: BRAIN Biotech announces buy-out of minorities, new continental European production site, and expansion of its Baking Application Center
EQS-News: BRAIN Biotech announces buy-out of minorities, new continental European production site, and expansion of its Baking Application Center
EQS-Adhoc: BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservative development for the second half of the fiscal year 2024/25
EQS-Adhoc: BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservative development for the second half of the fiscal year 2024/25
EQS-News: Results of the 2025 Annual General Meeting for the 2023/24 financial year of BRAIN Biotech AG
EQS-News: Results of the 2025 Annual General Meeting for the 2023/24 financial year of BRAIN Biotech AG
EQS-News: BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growth in the core BRAINBiocatalysts division
EQS-News: BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growth in the core BRAINBiocatalysts division
EQS-News: Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative
EQS-News: Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative
EQS-News: Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects
EQS-News: Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects
EQS-News: BRAIN Biotech AG Sharpens Focus on Profitable Growth
EQS-News: BRAIN Biotech AG Sharpens Focus on Profitable Growth